Akkermansia muciniphila was isolated from human feces. It is a species of human intestinal mucin-degrading bacterium. It is a Gram-negative, strictly anaerobic, non-motile, non-spore-forming, oval-shaped bacterium.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
CAT | Size | Price | Quantity | |
---|---|---|---|---|
LBST-012FG |
|
Product Information | |
---|---|
Product Overview | Akkermansia muciniphila was isolated from human feces. It is a species of human intestinal mucin-degrading bacterium. It is a Gram-negative, strictly anaerobic, non-motile, non-spore-forming, oval-shaped bacterium. |
Target | Akkermansia |
Genus | Akkermansia |
Application | Study and research |
Type Strain | Yes |
Culture Medium | Thioglycolate medium |
Culture Conditions | 37°C; Anaerobic |
Source | Human feces |
Risk Group | 1 |
Product Format | Freeze-dried |
Packaging | Ampoule tube |
Storage | -80°C |
Shelf Life | 6 years |
Target Introduction | |
---|---|
Introduction | Akkermansia is a genus in the phylum Verrucomicrobia; Bacteria with the type species Akkermansia muciniphila. Among the next-generation beneficial microbes that have been identified, Akkermansia muciniphila is a promising candidate. Akkermansia muciniphila is a strict anaerobe recently isolated from human faeces and uses the mucin as thesole sources of carbon and nitrogen elements. Due to this unique function and its high universality and richness in almost all life stages, Akkermansia muciniphila opened new avenues for the application in next-generation therapeutic probiotic. It is a bacterium of oval shape, non-motile and Gram-negative andforms no endospores and widely distributed in the intestines of human and animals. Akkermansia muciniphila is one of the normal gutsymbionts throughout our life. Currently, a large number of researches on Akkermansia muciniphila mainly focused on explaining its relationship with diseases. It promises to be a therapeutic target in the microbiota-related diseases, such as colitis, metabolic syndrome, immune diseases and cancer. Preliminary human datasuggest oral administration of Akkermansia muciniphila safe, butits effect needs to be further verified in more human clinical trials in the near future. |
Alternative Names | Akkermansia muciniphila Derrien et al. |
Akkermansia muciniphila Derrien et al. should be stored at -80°C to maintain its viability and integrity. It is crucial to avoid repeated freeze-thaw cycles to prevent degradation and ensure consistent results in research applications.
Akkermansia muciniphila Derrien et al. requires anaerobic conditions for optimal growth. Researchers should use a suitable anaerobic chamber or system to maintain an oxygen-free environment. The ideal temperature for culturing is 37°C, with a growth medium that supports mucin degradation.
Akkermansia muciniphila Derrien et al. can be quantified using quantitative PCR (qPCR) targeting specific genetic markers unique to the strain. Additionally, flow cytometry and colony-forming unit (CFU) counting on selective agar plates are effective methods for quantification.
Akkermansia muciniphila Derrien et al. is widely used in studies related to gut microbiota, metabolic disorders, and immune system modulation. It serves as a model organism for understanding mucin degradation and its impact on gut health, obesity, and diabetes.
The viability of Akkermansia muciniphila Derrien et al. can be assessed using live/dead staining techniques combined with fluorescence microscopy or flow cytometry. Additionally, plating on selective media and monitoring colony formation provides an indication of viable bacterial counts.
Click the button below to contact us or submit your feedback about this product.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.